|
|
|
|
IntelGenx Receives FDA Complete Response Letter CPI-300
IntelGenx announced receipt of a Complete Response Letter from the U.S.Food and Drug Administration ("FDA") regarding the Company's New Drug Application ("NDA") for its antidepressant CPI-300, which it developed with Cary...
|
|
|
XenoPort Announces Extension of the Horizant PDUFA Date to February 11, 2010
SANTA CLARA, Calif.-- (BUSINESS WIRE) -- XenoPort, Inc.(Nasdaq:XNPT) announced today that the U.S. Food and Drug Administration (FDA) will not be taking an action today on the Horizant (gabapentin enacarbil) new drug application (...
|
|
|
Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulation
POINT RICHMOND, Calif., Feb.9 /PRNewswire-FirstCall/ Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced that the first patent covering the composition and method of use of Intermezzo (zolpidem tartrate sublingual tablet), the lead Transcept...
|
|
|
Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulation
POINT RICHMOND, Calif., Feb.9 /PRNewswire-FirstCall/ --Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced that the first patent covering the composition and method of use of Intermezzo (zolpidem tartrate sublingual tablet), the lead Transcept...
|
|
|
Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulation
POINT RICHMOND, Calif., Feb.9 /PRNewswire-FirstCall/ --Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced that the first patent covering the composition and method of use of Intermezzo (zolpidem tartrate sublingual tablet), the lead Transcept...
|
|
|
Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulation
POINT RICHMOND, Calif., Feb.9 /PRNewswire-FirstCall/ --Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced that the first patent covering the composition and method of use of Intermezzo (zolpidem tartrate sublingual tablet), the lead Transcept...
|
|
|
Daiichi Sankyo's subsidiary seeks approval for Alzheimer's type Dementia treatment in Japan
- Japanese Daiichi Sankyo Company Limited (TYO: 4568) said yesterday that its subsidiary, ASUBIO PHARMA CO LTD, submitted a New Drug Application (NDA) in Japan for the manufacturing and marketing of SUN Y7017, which was developed for the...
|
|
|
Seattle Genetics Reports Fourth Quarter and Year 2009 Financial Results and Provides 2010 Financial Outlook
BOTHELL, Wash.-- (BUSINESS WIRE) -- Seattle Genetics, Inc.(Nasdaq:SGEN) today reported financial results for the fourth quarter and year ended December 31, 2009. The company also highlighted recent product development activities and planned milestones and...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--ChemGenex Pharmaceuticals Limited (ASX:CXS - News) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--ChemGenex Pharmaceuticals Limited (ASX:CXS - News) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDAs Oncologic Drugs Advisory Committee Meeting Schedu
MELBOURNE, Australia & MENLO PARK, Calif.--(EON: Enhanced Online News)--ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDAs Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
MELBOURNE, Australia & MENLO PARK, Calif.ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDAs Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February ..
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public advisory meeting scheduled for 10 February 2010 has...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Schedule
MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--Feb 9, 2010 - ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA s Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
MELBOURNE, Australia & MENLO PARK, Calif.-- (BUSINESS WIRE) -- (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public advisory meeting...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDAs Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--ChemGenex Pharmaceuticals Limited (ASX: CXS.AX) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee ...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
(BUSINESS WIRE) ----ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public advisory meeting scheduled for 10...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee
BusinessWire - ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public advisory meeting scheduled for 10...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDAs Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public advisory meeting scheduled for 10 February 2010 has...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Schedule
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public advisory meeting scheduled for 10 February 2010 has...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public advisory meeting scheduled for 10 February 2010 has...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDAEURs Oncologic Drugs Advisory Committee Meeting Sche
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public advisory meeting scheduled for 10 February 2010 has...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)-- ChemGenex Pharmaceuticals Limited (ASX: CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee ...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S.Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) public advisory meeting scheduled for 10 February 2010 has...
|
|
|
Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
GA_googleFillSlot("Press336"); GA_googleFillSlot("Press160"); MELBOURNE, Australia & MENLO PARK, Calif.- (Business Wire) ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S. Food and Drug Administration (FDA) has notified the...
|
